Steven Cohen Neuro Pace Inc Transaction History
Point72 Asset Management, L.P.
- $42.2 Billion
- Q4 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Neuro Pace Inc stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 32,943 shares of NPCE stock, worth $365,337. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,943Holding current value
$365,337% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding NPCE
# of Institutions
61Shares Held
21.4MCall Options Held
23.5KPut Options Held
100-
Kck Ltd. Tortola, D85.27MShares$58.5 Million78.74% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.41MShares$37.8 Million1.03% of portfolio
-
Morgan Stanley New York, NY2.49MShares$27.6 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.43MShares$27 Million1.9% of portfolio
-
Kent Lake Pr LLC Anasco, PR1.48MShares$16.4 Million7.02% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $276M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...